FactaeThe Factual News

Valneva awaits FDA decision on its clinical dossier

Valneva announces an imminent FDA decision on its clinical dossier.

Published 1sem1 sourceNotableupdated 1sem
Lire en français
≈ 15s

The fact

The submission was managed during the TCT congress in August 2026.

This step could impact the laboratory's stock price.

Click the link to read an article on the topic:
Explore this topic
What if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.
États-UnisWorld map →
Follow topic →
Auto-synthesis from 1 media source · identified on August 17, 2026
← Back to home
Discover

Read more

All marches →
marches

VALNEVA submits regulatory file to FDA for its vaccine

2sem · 1 sourcemarches

Valneva awaited on regulatory filing for Lyme vaccine authorization

18sem · 1 sourcemarches15 %

Valneva soars on US market after promising results

8sem · 1 sourcemarches12 %

Valneva surges following favorable stock market decision

5sem · 1 sourcemarches

Valneva opens sharply higher on Wall Street ahead of quarterly results

1sem · 1 sourcemarches

Valneva: investors await major 84-million capital raise

11sem · 1 source